About this Journal Submit a Manuscript Table of Contents
Journal of Skin Cancer
Volume 2013 (2013), Article ID 973123, 6 pages
http://dx.doi.org/10.1155/2013/973123
Review Article

Imaging in Patients with Merkel Cell Carcinoma

Department of Otolaryngology Head and Neck Surgery, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria

Received 24 October 2012; Accepted 4 January 2013

Academic Editor: Justin Lee

Copyright © 2013 Elisabeth Enzenhofer et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Suárez, J. P. Rodrigo, A. Ferlito, K. O. Devaney, and A. Rinaldo, “Merkel cell carcinoma of the head and neck,” Oral Oncology, vol. 40, no. 8, pp. 773–779, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Peloschek, C. Novotny, C. Mueller-Mang et al., “Diagnostic imaging in Merkel cell carcinoma: lessons to learn from 16 cases with correlation of sonography, CT, MRI and PET,” European Journal of Radiology, vol. 73, no. 2, pp. 317–323, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Toker, “Trabecular carcinoma of the skin,” Archives of Dermatology, vol. 105, no. 1, pp. 107–110, 1972. View at Publisher · View at Google Scholar · View at Scopus
  4. C. K. Tang, C. Toker, A. Nedwich, and A. N. F. Zaman, “Unusual cutaneous carcinoma with features of small cell (oat cell-like) and squamous cell carcinomas. A variant of malignant merkel cell neoplasm,” American Journal of Dermatopathology, vol. 4, no. 6, pp. 537–548, 1982. View at Scopus
  5. B. D. Nguyen and A. E. McCullough, “Imaging of merkel cell carcinoma,” Radiographics, vol. 22, no. 2, pp. 367–376, 2002. View at Scopus
  6. C. L. Hitchcock, K. I. Bland, R. G. Laney, D. Franzini, B. Harris, and E. M. Copeland III, “Neuroendocrine (Merkel cell) carcinoma of the skin. Its natural history, diagnosis, and treatment,” Annals of Surgery, vol. 207, no. 2, pp. 201–207, 1988. View at Scopus
  7. W. J. O’Connor and D. G. Brodland, “Merkel cell carcinoma,” Dermatologic Surgery, vol. 22, pp. 262–267, 1996. View at Publisher · View at Google Scholar
  8. F. Eftekhari, S. Wallace, E. G. Silva, and R. Lenzi, “Merkel cell carcinoma of the skin: imaging and clinical features in 93 cases,” British Journal of Radiology, vol. 69, no. 819, pp. 226–233, 1996. View at Scopus
  9. M. L. Haag, L. F. Glass, and N. A. Fenske, “Merkel cell carcinoma: diagnosis and treatment,” Dermatologic Surgery, vol. 21, no. 8, pp. 669–683, 1995. View at Scopus
  10. M. Heath, N. Jaimes, B. Lemos et al., “Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features,” Journal of the American Academy of Dermatology, vol. 58, no. 3, pp. 375–381, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. L. Jeremiah, J. L. Messina, S. S. Marzban et al., “Merkel cell carcinoma of unknown primary origin,” Annals of Surgical Oncology, vol. 19, no. 7, pp. 2360–2366, 2012. View at Publisher · View at Google Scholar
  12. E. J. Kim, H. S. Kim, H. O. Kim et al., “Merkel cell carcinoma of the inguinal lymph node with an unknown primary site,” Journal of Dermatology, vol. 36, no. 3, pp. 170–173, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. I. S. Winer, F. Lonardo, S. C. Johnson, and G. Deppe, “Merkel cell carcinoma in a patient with noninvasive vulvular Paget’s disease,” American Journal of Obstetrics & Gynecology, vol. 207, no. 1, pp. e9–e11, 2012. View at Publisher · View at Google Scholar
  14. M. Agelli, L. X. Clegg, J. C. Becker, and D. E. Rollison, “The etiology and epidemiology of merkel cell carcinoma,” Current Problems in Cancer, vol. 34, no. 1, pp. 14–37, 2010. View at Publisher · View at Google Scholar
  15. J. C. Becker, “Merkel cell carcinoma,” Annals of Oncology, vol. 21, no. 7, pp. vii81–vii85, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. E. Ramahi, J. Choi, C. D. Fuller, and T. Y. Eng, “Merkel cell carcinoma,” American Journal of Clinical Oncology, pp. 1–10, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Jank, P. Robatscher, R. Emshoff, H. Strobl, G. Gojer, and B. Norer, “The diagnostic value of ultrasonography to detect occult lymph node involvement at different levels in patients with squamous cell carcinoma in the maxillofacial region,” International Journal of Oral and Maxillofacial Surgery, vol. 32, no. 1, pp. 39–42, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. J. F. Griffith, A. C. W. Chan, A. T. Ahuja et al., “Neck ultrasound in staging squamous oesophageal carcinoma—a high yield technique,” Clinical Radiology, vol. 55, no. 9, pp. 696–701, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. T. P. Jessup, W. Y. Wassef, R. K. Yantiss, and K. Bhattacharya, “Metastatic Merkel cell carcinoma diagnosed by EUS-guided FNA of a rapidly progressive peripancreatic mass,” Gastrointestinal Endoscopy, vol. 63, no. 3, pp. 527–529, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Bernstein, A. J. Adeniran, G. Cal et al., “Endoscopic ultrasound-guided fine needle aspiration diagnosis of merkel cell carcinoma metastatic to the pancreas,” Diagnostic Cytopathology, 2012. View at Publisher · View at Google Scholar
  21. S. Sanchez-Gàrcia, C. Manzanares-Campillo, P. Menéndez-Sànchez, V. Munoz- Atienza, and J. Martin-Fernández, “Merkel cell carcinoma and literature review,” Cirugia y Cirujanos, vol. 80, no. 1, pp. 63–66, 2012.
  22. L. Stoll, S. Mudali, and S. Z. Ali, “Merkel cell carcinoma metastatic to the thyroid gland: aspiration findings and differential diagnosis,” Diagnostic Cytopathology, vol. 38, no. 10, pp. 754–757, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. B. T. Collins, P. G. Elmberger, E. M. Tani, V. Bjornhagen, and R. R. Ramos, “Fine-needle aspiration of Merkel cell carcinoma of the skin with cytomorphology and immunocytochemical correlation,” Diagnostic Cytopathology, vol. 18, no. 4, pp. 251–257, 1998. View at Publisher · View at Google Scholar
  24. F. J. Civantos, S. J. Stoeckli, R. P. Takes et al., “What is the role of sentinel lymph node biopsy in the management of oral cancer in 2010?” European Archives of Oto-Rhino-Laryngology, vol. 267, no. 6, pp. 839–844, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Brodsky, J. S. Zager, and C. G. Berman, “Imaging of merkel cell carcinoma,” in Merkel Cell Carcinoma: A Multidisciplinary Approach, chapter 9, pp. 159–169, 2010.
  26. J. Ortin-Perez, M. C. van Rijk, R. A. Valdes-Olmos et al., “Lymphatic mapping and sentinel node biopsy in Merkel's cell carcinoma,” European Journal of Surgical Oncology, vol. 33, no. 1, pp. 119–122, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. W. K. Stadelmann, L. Cobbins, E. J. Lentsch, and J. J. Disa, “Incidence of nonlocalization of sentinel lymph nodes using preoperative lymphoscintigraphy in 74 consecutive head and neck melanoma and Merkel cell carcinoma patients,” Annals of Plastic Surgery, vol. 52, no. 6, pp. 546–550, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. S. P. L. Leong, T. A. Achtem, F. A. Habib et al., “Discordancy between clinical predictions vs lymphoscintigraphic and intraoperative mapping of sentinel lymph node drainage of primary melanoma,” Archives of Dermatology, vol. 135, no. 12, pp. 1472–1476, 1999. View at Scopus
  29. M. B. Colgan, T. I. Tarantola, A. L. Weaver et al., “The predictive value of imaging studies in evaluating regional lymph node involvement in merkel cell carcinoma,” Journal of the American Academy of Dermatology, vol. 67, no. 6, pp. 1250–1256, 2012. View at Publisher · View at Google Scholar
  30. M. J. Gollub, D. R. Gruen, and D. David Dershaw, “Merkel cell carcinoma: CT findings in 12 patients,” American Journal of Roentgenology, vol. 167, no. 3, pp. 617–620, 1996. View at Scopus
  31. L. I. Canales, A. Parker, and S. Kadakia, “Upper gastrointestinal bleeding from Merkel cell carcinoma,” American Journal of Gastroenterology, vol. 87, no. 10, pp. 1464–1466, 1992. View at Scopus
  32. L. Azizi, K. Marsot-Dupuch, P. Bigel, S. Mzali, B. Meyer, and J. M. Tubiana, “Merkel cell carcinoma: a rare cause of hypervascular nasal tumor,” American Journal of Neuroradiology, vol. 22, no. 7, pp. 1389–1393, 2001. View at Scopus
  33. P. Dunlop, H. Sapp, P. M. Logan, and N. M. G. Walsh, “Merkel cell carcinoma of the abdominal wall,” Skeletal Radiology, vol. 27, no. 7, pp. 396–399, 1998. View at Publisher · View at Google Scholar · View at Scopus
  34. S. E. Anderson, K. T. Beer, A. Banic et al., “MRI of Merkel cell carcinoma: histologic correlation and review of the literature,” American Journal of Roentgenology, vol. 185, no. 6, pp. 1441–1448, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. F. Ikawa, K. Kiya, T. Uozumi et al., “Brain metastasis of merkel cell carcinoma: case report and review of the literature,” Neurosurgical Review, vol. 22, no. 1, pp. 54–57, 1999. View at Publisher · View at Google Scholar · View at Scopus
  36. D. J. Kwekkeboom, A. M. Hoff, S. W. J. Lamberts, H. Yoe Oei, and E. P. Krenning, “Somatostatin analogue scintigraphy: a simple and sensitive method for the in vivo visualization of Merkel cell tumors and their metastases,” Archives of Dermatology, vol. 128, no. 6, pp. 818–821, 1992. View at Publisher · View at Google Scholar · View at Scopus
  37. B. K. Durani, A. Klein, M. Henze, U. Haberkorn, and W. Hartschuh, “Somatostatin analogue scintigraphy in Merkel cell tumours,” British Journal of Dermatology, vol. 148, no. 6, pp. 1135–1140, 2003. View at Publisher · View at Google Scholar · View at Scopus
  38. P. Guitera-Rovel, J. Lumbroso, M. S. Gautier-Gougis et al., “Indium-111 octreotide scintigraphy of Merkel cell carcinomas and their metastases,” Annals of Oncology, vol. 12, no. 6, pp. 807–811, 2001. View at Publisher · View at Google Scholar · View at Scopus
  39. C. O. Wong, A. N. Pham, and H. J. Dworkin, “F-18 FDG accumulation in an octreotide negative merkel cell tumor,” Clinical Positron Imaging, vol. 3, no. 2, pp. 71–73, 2000. View at Publisher · View at Google Scholar · View at Scopus
  40. E. G. Eising, D. Bier, E. J. Knust, and C. Reiners, “Somatostatin-receptor scintigraphy methods-indications-results,” Radiologe, vol. 36, no. 1, pp. 81–88, 1996. View at Scopus
  41. V. A. Smith, E. Ramssay Camp, and E. J. Lentsch, “Merkel cell carcinoma: identification of prognostic factors unique to tumors located in the head and neck based on analysis of SEER Data,” Laryngoscope, vol. 122, pp. 1283–1290, 2012. View at Publisher · View at Google Scholar
  42. T. Belhocine, G. E. Pierard, J. Frühling et al., “Clinical added-value of 18FDG PET in neuroendocrine-merkel cell carcinoma,” Oncology Reports, vol. 16, no. 2, pp. 347–352, 2006. View at Scopus
  43. R. Concannon, G. S. Larcos, and M. Veness, “The impact of 18F-FDG PET-CT scanning for staging and management of Merkel cell carcinoma: results from Westmead Hospital, Sydney, Australia,” Journal of the American Academy of Dermatology, vol. 62, no. 1, pp. 76–84, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Iagaru, A. Quon, I. R. McDougall, and S. S. Gambhir, “Merkel cell carcinoma: is there a role for 2-Deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography/computed tomography?” Molecular Imaging and Biology, vol. 8, no. 4, pp. 212–217, 2006. View at Publisher · View at Google Scholar · View at Scopus
  45. J. N. Talbot, K. Kerrou, F. Missoum et al., “6-[F-18]fluoro-L-DOPA positron emission tomography in the imaging of Merkel cell carcinoma: preliminary report of three cases with 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography or pentetreotide-(111In) SPECT data,” Molecular Imaging and Biology, vol. 7, no. 4, pp. 257–261, 2005. View at Scopus
  46. S. G. Gupta, L. C. Wang, P. F. Peñas, M. Gellenthin, S. J. Lee, and P. Nghiem, “Sentinel lymph node biopsy for evaluation and treatment of patients with Merkel cell carcinoma: the Dana-Farber experience and meta-analysis of the literature,” Archives of Dermatology, vol. 142, no. 6, pp. 685–690, 2006. View at Publisher · View at Google Scholar · View at Scopus
  47. J. L. Lampreave, F. Bénard, A. Alavi, J. Jimenez-Hoyuela, and D. Fraker, “PET evaluation of therapeutic limb perfusion in Merkel's cell carcinoma,” Journal of Nuclear Medicine, vol. 39, no. 12, pp. 2087–2090, 1998. View at Scopus
  48. G. Maury, O. Dereure, A. Du-Thanh, D. Mariano-Goulart, and B. Guillot, “Interest of (18)F-FDG PET-CT scanning for staging and management of merkel cell carcinoma: a retrospective study of 15 patients,” Journal of the European Academy of Dermatology and Venereology, vol. 25, no. 12, pp. 1420–1427, 2011. View at Publisher · View at Google Scholar
  49. R. K. Grewal, N. Pandit-Taskar, M. Gonen, and S. M. Larson, “FDG-PET for evaluation of Merkel cell carcinoma,” Journal of Nuclear Medicine, vol. 46, no. 2, abstract 137, 2005.
  50. O. Warburg, K. Posener, and E. Negelein, “The metabolism of cancer cells,” Biochemischen Zeitschrift, vol. 152, pp. 129–169, 1924.
  51. G. Larcos and M. N. Maisey, “FDG-PET screening for cerebral metastases in patients with suspected malignancy,” Nuclear Medicine Communications, vol. 17, no. 3, pp. 197–198, 1996. View at Scopus